The Cardiovascular Metabolism Learning Zone explores current thinking in the management of type 2 diabetes and hypertension with international experts offering their insights and opinions on topics such as clinical inertia and individualisation of management of type 2 diabetes, and combination therapy for the management of hypertension.
Developed by EPG Health for Medthority in collaboration with Novartis Pharma AG, with content provided by Novartis Pharma AG. The views presented in the videos are those of the presenters and not necessarily those of the industry sponsor, Novartis Pharma AG. Time2DoMore is a trademark owned by Novartis Pharma AG. Following codes supersede any other material reference number appearing on the assets: GLEM/GAL/0072, 75, 79, 84, 99. Diabetes Clinical Trials: Date of preparation August 2020 GLEM/GAL/0115.